Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;42(6):2659-2678.
doi: 10.1007/s12325-025-03185-9. Epub 2025 Apr 19.

Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments

Affiliations
Review

Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments

Kazi Islam et al. Adv Ther. 2025 Jun.

Abstract

Diabetes mellitus is a metabolic disorder, characterized by elevated blood sugar levels (hyperglycemia) and insulin dysregulation. This disease is associated with morbidity and mortality, including significant potential vascular complications. High levels of hyperglycemia lead to not only elevated levels of reactive oxygen species but also advanced glycation end products, which are detrimental to the vascular endothelium and reduce protective compounds such as nitric oxide and prostacyclin. This damage contributes to the development of both macrovascular and microvascular complications. The present investigation explores the pathophysiological mechanisms of diabetic vascular complications and evaluates current management strategies, including lifestyle modifications, pharmacological treatments, and emerging therapies. The review underscores the importance of ongoing progress in diabetes management and patient education to lead to optimal patient-health outcomes and quality of life for individuals with diabetes mellitus.

Keywords: Diabetes mellitus; Endothelial dysfunction; Hyperglycemia; Pharmacological treatments; Vascular complications.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: Alan D Kaye is an Editorial Board member of Advances in Therapy. Alan Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All other authors (Kazi Islam, Rahib Islam, Ivan Nguyen, Hassan Malik, Humza Pirzadah, Barsha Shrestha, Isabella B. Lentz and Sahar Shekoohi) declare no conflict of interest. Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Similar articles

Cited by

References

    1. Sapra A, Bhandari P. Diabetes. In: StatPearls. Treasure Island: StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK560927/.
    1. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20–33. 10.1016/j.cmet.2012.11.012. - PMC - PubMed
    1. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34:2436–43. 10.1093/eurheartj/eht149. - PMC - PubMed
    1. Yang D-R, Wang M-Y, Zhang C-L, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol. 2024. 10.3389/fendo.2024.1359255. - PMC - PubMed
    1. Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, de Clerck E, Polivka J, Potuznik P, Polivka J, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14:21–42. 10.1007/s13167-023-00314-8. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources